Skip to main content
Back

Information for ruling 600011305

This section is Advance Tariff Ruling

Start date
27 Aug 2024
Expiry date
26 Aug 2027
Description
Human blood fractions Samples of plasma and serum Use: clinical trials, laboratory research or diagnostic purposes Packaging: in test tubes or blood collection tubes
Keywords
  • FOR SCIENTIFIC RESEARCH
  • FOR DIAGNOSTIC USE
  • BLOOD SERUM
  • PLASMA
  • HUMAN BLOOD
Justification
Classification has been determined in accordance with the following:- For the purposes of determining the commodity codes within which goods most appropriately fall, reg 3 (1) of The Customs Tariff (Establishment) (EU Exit) Regulations 2020 sets out that the rules of interpretation contained in the following have effect – a. Part Two (Goods Classification Table Rules of Interpretation) of the Tariff of the United Kingdom (Reg 3(1)(a)); and b. Notes to a section or chapter of the Goods Classification Table (Reg 3(1)(b)). General Interpretative Rules (GIR)s GIR 1 has been used to classify this product by the terms of heading 3002 - Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified GIR 5b has been used to identify the type of packaging – in test tubes or blood collection tubes GIR 6 has been used to classify the goods to subheading level 300212 - Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; Antisera and other blood fractions Also classified in accordance with: Chapter 39 note 1 HSEN to 3002